Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025

Change company Symbol lookup

Select an option...

PXSAW Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025

TAP Molson Coors Beverage Co

CLS Celestica Inc

TWOU 2U Inc

CGTX Cognition Therapeutics Inc

BHAT Blue Hat Interactive Entertainment Technology

DBTX Decibel Therapeutics Inc

CLSK CleanSpark Inc

AER AerCap Holdings NV

AOD Aberdeen Total Dynamic Dividend Fund

Industrials : Marine | Small Cap Value
Based in Greece

Company profile

Pyxis Tankers Inc. is a maritime transportation holding company. The Company is focused on the product tanker sector. It owns a fleet of six double hull product tankers: Pyxis Epsilon with carrying capacity of approximately 50,295 deadweight tonnage (dwt); Pyxis Theta with carrying capacity of approximately 51,795 dwt, Pyxis Malou with carrying capacity of over 50,667 dwt; Pyxis Delta with carrying capacity of approximately 46,616 dwt; Northsea Beta with carrying capacity of over 8,647 dwt, and Northsea Alpha with carrying capacity of approximately 8,615 dwt. Four of the Company's vessels in the fleet are medium-range (MR), product tankers, three have eco-efficient or eco-modified designs, and two of them are short-range tanker sister ships. Its fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel and fuel oil, as well as other liquid bulk items, such as vegetable oils and organic chemicals.

Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

5:18 pm ET May 4, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.06% higher to $660.86 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 2.99% to 4,300.17 and the Dow Jones Industrial Average rising 2.81% to 34,061.06. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $86.56 below its 52-week high ($747.42), which the company reached on April 8th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 1.07% to $180.20, Novartis AG ADR (NOVN.EB) rose 0.90% to $88.27, and Amgen Inc. (AMGN) rose 1.68% to $236.10. Trading volume (993,860) eclipsed its 50-day average volume of 638,469.

Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

May 04, 2022 17:18 ET (21:18 GMT)